Harmony Biosciences Holdings (HRMY) EV to EBITDA (2020 - 2026)
Harmony Biosciences Holdings' (HRMY) EV to EBITDA stood at 5.66 in Q2 2026, up 11.0% from 5.10 a year earlier and up 24.1% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) EV to EBITDA (2020 - 2026) Analysis & Trends
On a TTM basis, Harmony Biosciences Holdings' EV to EBITDA came in at -2.50 as of Jun 30, 2026; for FY2025, it was 5.92, down 15.1% from FY2024.
- Across earlier years, EV to EBITDA came in at 6.97 in FY2024 (+2.0%), 6.84 in FY2023 (-66.8%), 20.63 in FY2022 (-3.5%) and 21.38 in FY2021 (-17.2%).
- Quarterly EV to EBITDA has ranged from 3.67 in Q3 2025 to 24.08 in Q3 2021 over the past five years.
- On a year-over-year basis, EV to EBITDA rose in three of the last eight quarters, with an average decline of 10.7%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 35.4% in Q3 2024, against a decline of 66.8% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 4.56 (Q1 2026), 5.92 (Q4 2025) and 3.67 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | -540.66 Mn | 198.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.66 |
| Mar 31, 2026 | 4.56 |
| Dec 31, 2025 | 5.92 |
| Sep 30, 2025 | 3.67 |
| Jun 30, 2025 | 5.10 |
| Mar 31, 2025 | 6.38 |
| Dec 31, 2024 | 6.97 |
| Sep 30, 2024 | 9.37 |
| Jun 30, 2024 | 6.75 |
| Mar 31, 2024 | 6.72 |
| Dec 31, 2023 | 6.81 |
| Sep 30, 2023 | 6.88 |
| Jun 30, 2023 | 10.07 |
| Mar 31, 2023 | 10.15 |
| Dec 31, 2022 | 20.39 |
| Sep 30, 2022 | 18.56 |
| Jun 30, 2022 | 19.81 |
| Mar 31, 2022 | 21.72 |
| Dec 31, 2021 | 20.94 |
| Sep 30, 2021 | 23.20 |
API Access
Harmony Biosciences Holdings EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();